BKR vs CLB: Which Stock Is the Better Buy?
Baker Hughes Company and Core Laboratories Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Energy.
AI verdict — BKR vs CLB, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| Baker Hughes Company (BKR) | Core Laboratories Inc. (CLB) | |
|---|---|---|
| Market cap | $60.0B | $0.6B |
| Revenue (latest FY) | $27.73B | $526.52M |
| Net income (latest FY) | $2.59B | $31.80M |
| Revenue growth (5y CAGR) | 6.0% | 2.9% |
| Net margin | 9.3% | 6.0% |
| Return on equity | 13.7% | 12.0% |
| P/E ratio | 19.5 | 21.9 |
| Dividend yield | 1.5% | 0.3% |
| Profitable years (of last 10) | 5 | 5 |
| Positive free cash flow | Yes | Yes |
Verify the comparison
Use the filing period and source shown by each tool before treating two figures as comparable.
See the full BKR vs CLB breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open BKR's full financials → Open CLB's full financials →Frequently asked questions
Which is bigger, BKR or CLB?
Baker Hughes Company is larger by market capitalization — $60.0B versus $0.6B.
Which grows faster, BKR or CLB?
Over the last five fiscal years, Baker Hughes Company grew revenue faster — 6.0%/yr versus 2.9%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.